Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1476-5470

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients ; volume:23 ; number:8 ; day:16 ; month:2 ; year:2022 ; pages:255-259 ; date:12.2022
Genes and immunity ; 23, Heft 8 (16.2.2022), 255-259, 12.2022

Creator: Van Gool, Stefaan W.
Makalowski, Jennifer
Bitar, Michael
Van de Vliet, Peter
Schirrmacher, Volker
Stuecker, Wilfried

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41435-022-00162-y

URN: urn:nbn:de:101:1-2023022721053221692453

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:48 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Van Gool, Stefaan W.
Makalowski, Jennifer
Bitar, Michael
Van de Vliet, Peter
Schirrmacher, Volker
Stuecker, Wilfried
SpringerLink (Online service)

Other Objects (12)

MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study

MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma

Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma

Wild-type IDH1 inhibition enhances chemotherapy response in melanoma

Wild-type and mutated IDH1/2 enzymes and therapy responses

Hochschulschrift

Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma : = Geschlechtsspezifische klinisch-pathologische Signifikanz neuer (Frizzled-7) sowie etablierter (MGMT, IDH1) Biomarker bei Glioblastomen

Surgery for IDH1/2 wild-type glioma invading the corpus callosum

Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients

Tumorzellgehalt in Glioblastomen : Zu TERT-Promotormutationen, MGMT-Methylierung und prognostischer Bedeutung von 'Reinheit' in GBM

A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]

MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study

MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma

Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma

Wild-type IDH1 inhibition enhances chemotherapy response in melanoma

Wild-type and mutated IDH1/2 enzymes and therapy responses

Hochschulschrift

Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma : = Geschlechtsspezifische klinisch-pathologische Signifikanz neuer (Frizzled-7) sowie etablierter (MGMT, IDH1) Biomarker bei Glioblastomen

Surgery for IDH1/2 wild-type glioma invading the corpus callosum

Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients

Tumorzellgehalt in Glioblastomen : Zu TERT-Promotormutationen, MGMT-Methylierung und prognostischer Bedeutung von 'Reinheit' in GBM

A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]

MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study

MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma

Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma

Wild-type IDH1 inhibition enhances chemotherapy response in melanoma

Wild-type and mutated IDH1/2 enzymes and therapy responses

Hochschulschrift

Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma : = Geschlechtsspezifische klinisch-pathologische Signifikanz neuer (Frizzled-7) sowie etablierter (MGMT, IDH1) Biomarker bei Glioblastomen

Surgery for IDH1/2 wild-type glioma invading the corpus callosum

Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients

Tumorzellgehalt in Glioblastomen : Zu TERT-Promotormutationen, MGMT-Methylierung und prognostischer Bedeutung von 'Reinheit' in GBM

A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study

MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma

Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma

Wild-type IDH1 inhibition enhances chemotherapy response in melanoma

Wild-type and mutated IDH1/2 enzymes and therapy responses

Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma : = Geschlechtsspezifische klinisch-pathologische Signifikanz neuer (Frizzled-7) sowie etablierter (MGMT, IDH1) Biomarker bei Glioblastomen

Surgery for IDH1/2 wild-type glioma invading the corpus callosum

Surgery for IDH1/2 wild-type glioma invading the corpus callosum

Surgery for IDH1/2 wild-type glioma invading the corpus callosum

Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients

Tumorzellgehalt in Glioblastomen : Zu TERT-Promotormutationen, MGMT-Methylierung und prognostischer Bedeutung von 'Reinheit' in GBM

A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]

MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study

MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma

Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma

Wild-type IDH1 inhibition enhances chemotherapy response in melanoma

Wild-type and mutated IDH1/2 enzymes and therapy responses

Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma : = Geschlechtsspezifische klinisch-pathologische Signifikanz neuer (Frizzled-7) sowie etablierter (MGMT, IDH1) Biomarker bei Glioblastomen

Surgery for IDH1/2 wild-type glioma invading the corpus callosum

Surgery for IDH1/2 wild-type glioma invading the corpus callosum

Surgery for IDH1/2 wild-type glioma invading the corpus callosum

Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients

Tumorzellgehalt in Glioblastomen : Zu TERT-Promotormutationen, MGMT-Methylierung und prognostischer Bedeutung von 'Reinheit' in GBM

A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]

MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study

MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma

Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma

Wild-type IDH1 inhibition enhances chemotherapy response in melanoma

Wild-type and mutated IDH1/2 enzymes and therapy responses

Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma : = Geschlechtsspezifische klinisch-pathologische Signifikanz neuer (Frizzled-7) sowie etablierter (MGMT, IDH1) Biomarker bei Glioblastomen

Surgery for IDH1/2 wild-type glioma invading the corpus callosum

Surgery for IDH1/2 wild-type glioma invading the corpus callosum

Surgery for IDH1/2 wild-type glioma invading the corpus callosum

Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients

Tumorzellgehalt in Glioblastomen : Zu TERT-Promotormutationen, MGMT-Methylierung und prognostischer Bedeutung von 'Reinheit' in GBM

A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM]

Related objects

Reset password